After decades of clinical breakthroughs, Dana-Farber has helped increase survival rates and new treatment options for children with cancer. Yet, childhood cancer is still the leading cause of disease-related death in children in the United States. To help overcome this challenge, Dana-Farber’s Pediatric Cancer Genetic Risk Program brings together a team of physicians, genetic counselors, and researchers to help manage all aspects of genetic cancer risk. This discussion is about how Dana-Farber is leading the way in transforming the prevention and treatment of cancer in children. Panelists were joined by a patient family member with firsthand experience with this program.